Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Therapeutic Agent Identification
This grant supports developing and screening assays to identify new therapeutic agents for neurological, aging-related, and pain disorders, focusing on non-addictive treatments.
Funder: National Institutes of Health
Due Dates (Anticipated): September 2026 (projected)
Funding Amounts: Award size and total program funding not yet specified; details to be announced in future solicitation.
Summary: Supports early-stage translational research for assay development and identification of potential therapeutic agents for neurological and related disorders.
Key Information: This is a forecasted opportunity; applications are not yet being solicited.
Description
This forecasted grant opportunity, administered by the National Institutes of Health (NIH), aims to support early-stage translational research focused on developing in vitro, ex vivo, or in vivo assays and conducting screening efforts to identify and characterize potential therapeutic agents. The program targets disorders or diseases supported by participating NIH Institutes and Centers, with a particular emphasis on non-opioid analgesic therapeutics with minimal addiction liability as part of the NIH Helping to End Addiction Long Term (HEAL) initiative. Eligible projects may involve small molecules, biologics, and the use of New Approach Methodologies (NAMs) where appropriate. This notice is provided to allow prospective applicants time to develop collaborations and prepare responsive projects; applications are not currently being accepted.
